Cardiomyocytes and non-muscle cells in cardiac hypertrophy: A molecular perspective

Progress in Pediatric Cardiology

Volumn 9, Issue 3, 1998, Pages 183-197

  Gupta, Madhu ^a,b   Gupta, Mahesh P ^c   Arcilla, Rene A ^a   Zak, Radovan ^c  

^a ADVOCATE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Angiotensin II; Collagen; Gene transcription; Growth factors; Heart failure; Integrins; Nitric oxide; Phenotype; Signal transduction

Indexed keywords

ANGIOTENSIN; CARRIER PROTEIN; CONTRACTILE PROTEIN; ENDOTHELIN; GROWTH FACTOR; NEUROHORMONE; PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; ENDOTHELIUM CELL; FIBROBLAST; GENETIC TRANSCRIPTION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART WORK; MOLECULAR DYNAMICS; MORBIDITY; MORTALITY; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; VASCULAR SMOOTH MUSCLE;

EID: 0032450903     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(99)00005-3     Document Type: Article

References (81)

1. Zak R Cell proliferation during cardiac growth. Am J Cardiol. 31:1973;211-219.
2. Bugaisky LB, Gupta M, Gupta MP et al. Cellular and molecular mechanisms of cardiac hypertrophy. In: Fozzard HA et al., editors. The Heart and Cardiovascular System, 2nd edn. New York: Raven Press, 1992:1621-1640.
3. Chien KR, Knowlton KU, Zhu Het al. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiological response. FASEB J. 5:1991;3037-3046.
4. Sutsch G, Brunner UT, von Schulthess Cet al. Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement. Circ Res. 70:1992;1035-1043.
5. Swynghedauw B Remodeling of the heart in chronic pressure overload. Basic Res Cardiol. 86(1):1991;99-105.
6. Alpert NR, Periasamy M, Arai M et al. The regulation of calcium cycling in stressed hearts. In: Holtz J et al., editors. Cardiac Adaptation in Heart Failure. Steinkopff Verlag, 1992.
7. Tsutsui H, Ishibashi Y, Imanaka-Yoshida Ket al. Alterations in sarcoplasmic reticulum calcium-storing proteins in pressure-overload cardiac hypertrophy. Am J Physiol. 272(1 Pt 2):1997;H168-75.
8. Sachs F Mechanical transduction by membrane ion channels. Mol Cell Biochem. 104:1991;57-60.
9. 2+ exchanger in response to pressure overload. Am J Physiol. 265:1993;H1024-H1029.
10. Hamill OP, McBride DW Rapid adaptation of the mechanosensitive channel in Xenopus oocytes. Proc Natl Acad Sci USA. 89:1992;7462-7466.
11. Charlemagne D, Orlowski J, Oliviero Pet al. Alteration of Na-K-ATPase subunit mRNA and protein levels in hypertrophied rat heart. J Biol Chem. 269:1994;1541-1547.
12. Tsutsui H, Ishihara K, Cooper G Cytoskeletal role in the contractive dysfunction of hypertrophied myocardium. Science. 260:1993;682-687.
13. Chien KR, Zhu H, Knowlton KUet al. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol. 55:1993;77-95.
14. Sindhwani R, Ismail-Beigi F, Leinwand LA Post-transcriptional regulation of rat α cardiac myosin heavy chain gene expression. J Biol Chem. 269:1994;3272-3276.
15. Firulli AB, Olson EN Modular regulation of muscle gene transcription: a mechanism for muscle cell diversity. Trends Genet. 13(9):1997;364-369.
16. 1-adrenergic agonist and activated β-protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem. 269:1994;3775-3782.
17. Gupta MP, Gupta M, Zak R An E-Box/M-CAT motif and cognate binding proteins regulate the basal muscle-specific and cAMP inducible expression of rat cardiac α-myosin heavy chain gene. J Biol Chem. 47:1994;29677-29687.
18. Gupta MP, Amin CR, Gupta M, May N, Zak R Transcription enhancer factor-1 interacts with a basic helix-hoop-helix zipper protein, Max, for positive regulation of cardiac α-myosin heavy chain gene expression. Mol Cell Biol. 17:1997;3924-3936.
19. 1-adrenergic induction of the skeletal α-actin promoter during cardiac myocyte hypertrophy. J Biol Chem. 270:1995;410-417.
20. Hasegawa K, Lee SJ, Jobe SM, Markham BE, Kitsis RN Cis-acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation. 96(11):1997;3943-3953.
21. Kovacic-Milivojevic B, Wong VSH, Gardner DG Selective regulation of the atrial natriuretic peptide gene by individual components of the activator protein-1 complex. Endocrinology. 137:1996;1008-1117.
22. Paradis P, MacLellan WR, Belaguli NS, Schwartz RJ, Schneider MD Serum response factor mediates AP-1-dependent induction of the skeletal α-actin promoter in ventricular myocytes. J Biol Chem. 271:1996;10827-10833.
23. Molketin JD, Lu JR, Antos CLet al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93(2):1998;215-228.
24. Sussman MA, Lim HW, Gude Net al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 281:1998;1690-1693.
25. Izumo S, Lompre AM, Matsuoka Ret al. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest. 79:1987;970-977.
26. Gupta M, Zak R Reversibility of load-induced changes in myosin heavy chain gene expression. Am J Physiol. 262:1992;R346-R349.
27. Gupta M, Zak R, Libermann TA, Gupta MP. Tissue restricted expression of the cardiac α-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two Ets binding sites. Mol Cell Biol 1998;18(12):(In Press).
28. Booz GW, Baker KM Molecular signaling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res. 30:1995;537-543.
29. Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ Angiotensin II stimulates the autocrine production of transforming growth factor-β-1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol. 27:1995;2347-2357.
30. Villarreal FJ, Lee AA, Dillmann WH, Giordano FJ Adenovirus-mediated overexpression of human transforming growth factor β-1 in rat cardiac fibroblasts, myocytes and smooth muscle cells. J Mol Cell Cardiol. 28:1996;735-742.
31. Sigel A, Douglas JA, Eghbali-Webb M Regulation of mRNA transcripts and DNA synthesis in the rat heart following intravenous injection of transforming growth factor β-1. Mol Cell Biochem. 141:1994;145-151.
32. 1, fibronectin, and collagen. Am J Physiol. 262:1992;H1861-1866.
33. Wilke A, Funck R, Rupp H, Brilla CG Effect of the renin-angiotensin-aldosterone system on the cardiac interstitium in heart failure. Basic Res Cardiol. 91(2):1996;79-84.
34. Yanagisawa M, Kurihara H, Kimura Set al. A novel potent vasoconstrictive peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
35. Ionue A, Yanagisawa M, Kimura Set al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 86:1989;2863-2867.
36. MacCumber MW, Ross CA, Snyder SH Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA. 86:1989;7285-7289.
37. Yorikane R, Sakai S, Miyauchi T, Sakurai T, Sugishita Y, Goto K Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett. 332:1993;31-34.
38. Ito H, Hiroe M, Hirata Yet al. Endothelin A receptor antagonist (BQ123) blocks cardiac hypertrophy provoked by pressure overload. Circulation. 89:1994;2198-2203.
39. Ito H, Hirata Y, Adachi Set al. Endothelin-1 is an autocrine/paracrine factor in the myocardium of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 92:1993;398-403.
40. Shubeita HE, McDonough PM, Harris ANet al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J Biol Chem. 265:1990;20553-20562.
41. Ito H, Hirata Y, Miroe Met al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 69:1991;209-215.
42. Hasegawa K, Fujiwara H, Koshiji Met al. Endothelin-1 and its receptor in hypertrophic cardiomyopathy. Hypertension. 27:1996;259-264.
43. Moncada S, Palmer RMJ, Higgs EA Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 43:1991;109-142.
44. Joe EK, Schussheim AE, Longrois Det al. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J Mol Cell Cardiol. 30(2):1998;303-315.
45. Kung CF, Moreau P, Takase H, Luscher TF L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Hypertension. 26:1995;744-751.
46. Devlin AM, Brosnan MJ, Graham Det al. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol. 274:1998;H52-H59.
47. Hou J, Kato H, Cohen RA, Chobanian AV, Brecher P Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. J Clin Invest. 96:1995;2469-2477.
48. Borg TK, Rubin K, Carver W, Samarel A, Terracio L The cell biology of the cardiac interstitium. Trends Cardiovasc Med. 6:1996;65-70.
49. Parker TG, Schneider MD Growth factors, proto-oncogenes and plasticity of the cardiac phenotype. Ann Rev Physiol. 53:1991;179-200.
50. Parker TG Molecular biology of myocardial hypertrophy and failure: Gene expression and trophic signaling. New Horizons. 3:1995;288-299.
51. Schaub MC, Hefti MA, Harder BA, Eppenberger HM Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med. 75:1997;901-920.
52. Calderone A, Takahashi N, Izzo NJet al. Pressure and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotype and differential induction of peptide growth factor mRNA. Circulation. 92:1995;2385-2390.
53. Baker KM, Booz GW, Dostal DE Cardiac action of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 54:1992;227-241.
54. Sadoshima J, Xu Y, Slayter HSet al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
55. Sadoshima J, Malhotra R, Izumo S The role of the cardiac renin-angiotensin system in load-induced cardiac hypertrophy. J Cardiac Failure. 2:1996;S1-S6.
56. Dostal DE, Hunt RA, Kule CEet al. Molecular mechanisms of angiotensin II in modulating cardiac function. Intracardiac effects and signal transduction pathways. J Mol Cell Cardiol. 29:1997;2893-2902.
57. Funck RC, Wilke A, Rupp H, Brilla CG Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease. Adv Exp Med Biol. 432:1997;35-44.
58. Brilla CG, Zhou G, Rupp H, Maisch B, Weber KT Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol. 76:1995;8D-13D.
59. Bishop JE, Rhodes S, Laurent GJ, Low RB, Stirewalt WS Increased collagen synthesis and decreased collagen degradation in right ventricular hypertrophy induced by pressure overload. Cardiovasc Res. 28:1994;1581-1585.
60. Schwartz SM, Gordon D, Mosca RS, Bore EL, Heidelberger KP, Kulik TH Collagen content in normal, pressure and pressure-volume overloaded developing human hearts. Am J Cardiol. 77:1996;734-738.
61. Grossman W. Diastolic dysfunction and congestive heart failure. Circulation 1990;81(2)III:1-7.
62. MacKenna DA, Dolfi F, Vuori K, Ruoslathi E Extracellular signal regulated kinase and c-jun N-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. J Clin Invest. 101:1998;301-310.
63. Shyy JY-J, Chien S Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol. 9:1997;707-713.
64. Huckle WR, Prokp CA, Dy RCet al. Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner. Mol Cell Biol. 10:1990;6290-6298.
65. Komuro I, Yazaki Y Control of cardiac gene expression by mechanical stress. Ann Rev Physiol. 55:1993;55-75.
66. Grohe C, Nouskas J, Vetter H, Neyses L Effects of nisoldipine on endothelin-1 and angiotensin II induced immediate/early gene expression and protein synthesis in adult rat ventricular cardiomyocytes. J Cardiovasc Pharmacol. 24:1994;13-16.
67. Komuro I, Kudo S, Yazaki T, Zou Y, Shiojima I, Yazaki Y Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes. FASEB J. 10(5):1996;631-636.
68. 2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res. 80:1997;139-146.
69. Sadoshima S, Qui Z, Morgan JP, Izumo S Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes. EMBO J. 15(20):1996;5535-5546.
70. Wang Y, Huang S, Sah VPet al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 273:1998;2161-2168.
71. 1-adrenergic receptor and ras-activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem. 272:1997;14057-14061.
72. Sopontammarak S, Ingram PA, Gupta MP, Arcilla RA, Gupta M. Specific induction of p38 kinase activity in cardiac volume overload following aorto-caval shunt in rats. Ped Res 1998;43:A141 (abstr).
73. Gwathmey JK, Copelas L, MacKinnon Ret al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 61:1987;70-76.
74. Arai M, Alpert NR, MacLennan DHet al. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 72:1993;463-469.
75. Mercadier JJ, de la Bastie D, Menasche P Alpha myosin heavy chain isoform and atrial size in patients with various types of mitral dysfunction. A quantitative study. J Am Coll Cardiol. 9:1987;1024-1030.
76. Bouvagnet P, Mairhofer H, Leger JOet al. Distribution of alpha and beta myosin in normal and diseased human ventricular myocardium. Basic Res Cardiol. 84:1989;91-102.
77. Boluyt MO, O'Neill L, Meredith ALet al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ Res. 75:1994;23-32.
78. Lowes BD, Minobe W, Abraham WTet al. Changes in gene expression in the intact human heart: Down regulation of α-myosin heavy chain in hypertrophied failing myocardium. J Clin Invest. 100:1997;2315-2324.
79. Nakao K, Minobe W, Roden R, Bristow RM, Leindand LA Myosin heavy chain gene expression in the human heart failure. J Clin Invest. 100:1997;2362-2370.
80. Bing OH, Brooks WW, Conrad CH, Sen S, Perreault CL, Morgan JP Intracellular calcium transients in myocardium from spontaneously hypertensive rats during the transition to heart failure. Circ Res. 68:1991;1390-1400.
81. Jones WK, Grupp IL, Doetschman Tet al. Ablation of the murine α-heavy chain gene leads to dosage effects and function deficits in the heart. J Clin Invest. 98:1996;1906-1917.